 "Sri Lanka approves Chinese Sinovac Covid-19 vaccine for emergency use")
Sri Lanka has approved the emergency use of the Chinese Sinovac vaccine against COVID-19.
It is the second Chinese COVID-19 vaccine approved by Sri Lanka's National Medicines Regulatory Authority (NMRA), News First reported.
The country has already been administrating China's Sinopharm vaccine. China on Thursday announced that it will donate another 1.6 million doses of the Sinopharm COVID-19 vaccine to Sri Lanka.
Besides this, Covishield, Sputnik and Pfizer vaccines are also being administrated in the country.
Sinovac CoronaVac has been developed by Sinovac/China National Pharmaceutical Group.
In June, the WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for the use of the inactivated COVID-19 vaccine.
According to the data published by the Epidemiology Unit of the Ministry of Health showed that, as of Thursday, more than 51 lakh people have obtained their first shot in the island nation, which has a population of 2.18 crores.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app